Creative Planning
VBIV

Creative Planning’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Creative Planning’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-497
Closed -$35K – 2460
2021
Q4 		$35K Buy
+497
New +$41.9K ﹤0.01% 2018
2021
Q2 		– Sell
-9,736
Closed -$908K – 2657
2021
Q1 		$908K Sell
9,736
-2,000
-17% -$203K ﹤0.01% 1077
2020
Q4 		$968K Buy
11,736
+10,645
+976% +$908K ﹤0.01% 970
2020
Q3 		$94K Sell
1,091
-6,984
-86% -$814K ﹤0.01% 1834
2020
Q2 		$751K Buy
8,075
+5,238
+185% +$289K ﹤0.01% 850
2020
Q1 		$81K Buy
2,837
+2,270
+400% +$88.2K ﹤0.01% 1568
2019
Q4 		$23K Buy
+567
New +$12.4K ﹤0.01% 1870

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return